X
29Jul

National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer

On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By: Manatt, Phelps & Phillips, LLP
Source Url: https://www.jdsupra.com/legalnews/national-retailer-pulls-cbd-products-45233/

Related

Supreme Court: written disclosures not enough to show actual knowledge in ERISA suits

The United States Supreme Court unanimously decided last week that a plan participant who received w...

Read More >

Between A Rock And A Hard Place: Avoiding Accidental Liability Under FCRA for Background Checks

Many employers use background checks to guarantee it hires the best candidates—and to minimize lega...

Read More >

Antitrust M&A Snapshot - February 2020

Antitrust regulators in the United States and Europe were very active in the final quarter of 2019. ...

Read More >

Sexual Harassment In The Workplace: What US: Washington State Companies Need To Know

Below are summaries of recent laws adopted in Washington State that could be interpreted as relating...

Read More >

The Massachusetts Paid Family and Medical Leave Quarterly Contributions Are Due January 31, 2020

Under the new Massachusetts Paid Family and Medical Leave Law, M.G.L c. 175M (“MAPFML”), employees...

Read More >

Employment Flash - December 2019

This edition of Employment Flash looks at recent NLRB activity, including its issuance of a decision...

Read More >